Bluejay Diagnostics, Inc. has regained compliance with Nasdaq listing rules as its stock price has been above $1.00 per share, closing a previous deficiency issue.
AI Assistant
BLUEJAY DIAGNOSTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.